Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease

Tacrolimus Monotherapy after Intravenous Methylprednisolone in Adults with Minimal Change Nephrotic Syndrome

(2016) Xiayu Li et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Long-term Outcome of Biopsy-Proven Minimal Change Nephropathy in Chinese Adults

(2015) Cheuk-Chun Szeto et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Enhanced Steroid Therapy in Adult Minimal Change Nephrotic Syndrome: A Systematic Review and Meta-analysis

(2015) Lingfei Zhao et al.   INTERNAL MEDICINE

Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis

(2015) Ruyi Liao et al.   PLoS One

Comparison of Methylprednisolone Plus Prednisolone with Prednisolone Alone as Initial Treatment in Adult-Onset Minimal Change Disease: A Retrospective Cohort Study

(2014) M. Shinzawa et al.   Clinical Journal of the American Society of Nephrology

Retrospective Analysis of a Novel Regimen for the Prevention of Venous Thromboembolism in Nephrotic Syndrome

(2013) N. Medjeral-Thomas et al.   Clinical Journal of the American Society of Nephrology

Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories

(2013) Katherine M. Flegal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Treatment of Minimal Change Disease in Adults

(2013) J. Hogan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Tacrolimus as rescue therapy for adult-onset refractory minimal change nephrotic syndrome with reversible acute renal failure

(2013) X. Li et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab for minimal change disease in adults: long-term follow-up

(2013) A. Bruchfeld et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Epidemiology and Pathophysiology of Nephrotic Syndrome-Associated Thromboembolic Disease

(2012) B. A. Kerlin et al.   Clinical Journal of the American Society of Nephrology

Tacrolimus Versus Intravenous Pulse Cyclophosphamide Therapy in Chinese Adults With Steroid-Resistant Idiopathic Minimal Change Nephropathy: A Multicenter, Open-Label, Nonrandomized Cohort Trial

(2012) Heng Li et al.   CLINICAL THERAPEUTICS

Interaction Between Maintenance Steroid Dose and the Risk/Benefit of Steroid Avoidance and Withdrawal Regimens Following Renal Transplantation

(2011) Simon R. Knight et al.   TRANSPLANTATION

A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients

(2010) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial

(2009) Swati Choudhry et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Tacrolimus Therapy in Adults With Steroid- and Cyclophosphamide-Resistant Nephrotic Syndrome and Normal or Mildly Reduced GFR

(2009) Xiayu Li et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome

(2009) A. Eguchi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

High Absolute Risks and Predictors of Venous and Arterial Thromboembolic Events in Patients With Nephrotic Syndrome

(2007) Bakhtawar K. Mahmoodi et al.   CIRCULATION

Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome

(2007) X. Li et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION